Follow the Medexus Pharmaceuticals Inc. share price and the full directors' dealings record of the company, a publicly traded company based in Canada. Shares are quoted on the CA market, under the oversight of SEDI. Market capitalisation: €169.1m. The latest transaction was reported on 5 August 2026 (38 - Redemption, retraction, cancellation, repurchase). Among the most active insiders: Medexus Pharmaceuticals Inc.. The full history is free.
112
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Medexus Pharmaceuticals Inc. Strong Buy (bullish), based on 5 analysts. Average price target: CA$7.25.
12Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,339 of 29,062 companies
40.9
score / 100
Value
39
Quality
43
FCF yld2.3%
Earn yld-1.5%
EV/EBITDA14.3x
ROE-4.7%
Gross mgn55%
Net mgn-2.4%
Debt/EBITDA1.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Medexus Pharmaceuticals Inc. es una empresa farmacéutica centrada en el desarrollo y la comercialización de productos terapéuticos. Cotiza en la Bolsa de Valores de Toronto bajo el símbolo MDX.